Answer
Zavicefta’s ceftazidime component has been associated with Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, and acute generalised exanthematous pustulosis, reported at unknown frequency and potentially life-threatening or fatal.
Sources for this answer
- Zavicefta 2 g/0.5g powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 15Document updated
Sources checked